WARMINSTER, PA -- (MARKET WIRE) -- May 02, 2007 -- OraPharma, Inc., a specialty pharmaceutical company specializing in the discovery, development, and commercialization of therapeutics for the treatment of periodontal disease, including ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg, recently launched the third generation of its popular web site, www.ARESTIN.com.